{
  "calculator": "LI-RADS v2018",
  "version": "2018",
  "description": "Comprehensive test cases for LI-RADS (Liver Imaging Reporting and Data System) v2018 calculator covering all categories, size thresholds, major features, and ancillary adjustments",
  "medicalReferences": [
    {
      "citation": "Chernyak V, et al. Radiology. 2018;289(3):816-830",
      "doi": "https://doi.org/10.1148/radiol.2018181494",
      "description": "LI-RADS v2018 primary reference"
    },
    {
      "citation": "Cerny M, et al. RadioGraphics. 2018;38(7):1973-2001",
      "doi": "https://doi.org/10.1148/rg.2018180052",
      "description": "LI-RADS v2018 Ancillary Features"
    },
    {
      "citation": "Marrero JA, et al. Hepatology. 2018;68(2):723-750",
      "doi": "https://doi.org/10.1002/hep.29913",
      "description": "AASLD 2018 HCC Practice Guidance"
    }
  ],
  "testCases": [
    {
      "testName": "Not At-Risk Population - LI-RADS Not Applicable",
      "category": "Prerequisites",
      "description": "Patient not in at-risk population - LI-RADS should not be applied",
      "inputs": {
        "high_risk_population": false
      },
      "expectedOutputs": {
        "LI-RADS Status": "LI-RADS not applicable - Patient must be in at-risk population",
        "At-Risk Criteria": "Cirrhosis (non-vascular), chronic hepatitis B, or current/prior HCC",
        "Note": "LI-RADS should not be used for patients outside the at-risk population"
      },
      "calculationSteps": "Step 1: Check high_risk_population = false. Step 2: Return not applicable status as LI-RADS requires at-risk population.",
      "medicalReference": "LI-RADS v2018 Guidelines - Population criteria"
    },
    {
      "testName": "LR-NC - Inadequate Study Quality",
      "category": "LR-NC",
      "description": "Patient in at-risk population but study technically inadequate",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": false
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-NC (Not Categorizable)",
        "Definition": "Image omission or degradation precludes adequate evaluation",
        "Recommendation": "Repeat imaging with adequate technique"
      },
      "calculationSteps": "Step 1: Check high_risk_population = true (pass). Step 2: Check study_adequate = false. Step 3: Return LR-NC due to inadequate study quality.",
      "medicalReference": "LI-RADS v2018 - LR-NC definition"
    },
    {
      "testName": "LR-TIV - Tumor in Portal Vein",
      "category": "LR-TIV",
      "description": "Unequivocal enhancing soft tissue in portal vein - absolute contraindication to transplant",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": true
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-TIV (Tumor in Vein)",
        "Definition": "Definite tumor invasion of portal or hepatic veins",
        "Clinical Significance": "Indicates advanced disease stage",
        "Transplant Eligibility": "Contraindication to liver transplantation",
        "Recommendation": "Multidisciplinary discussion required",
        "Diagnostic Criteria": "Unequivocal enhancing soft tissue within a vein"
      },
      "calculationSteps": "Step 1: Check high_risk_population = true (pass). Step 2: Check study_adequate = true (pass). Step 3: Check tumor_in_vein = true. Step 4: Return LR-TIV category immediately.",
      "medicalReference": "Bae JS, et al. Radiology. 2021;302(1):107-115"
    },
    {
      "testName": "LR-1 - Definitely Benign (Simple Cyst)",
      "category": "LR-1",
      "description": "100% certainty benign observation such as simple cyst, hemangioma, or focal fat",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "definitely_benign"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-1 (Definitely Benign)",
        "HCC Probability": "0%",
        "Definition": "100% certainty benign (e.g., simple cyst, hemangioma, focal fat)",
        "Recommendation": "Return to routine surveillance"
      },
      "calculationSteps": "Step 1: Check prerequisites (at-risk, adequate study, no TIV) - all pass. Step 2: Check benign_status = 'definitely_benign'. Step 3: Return LR-1 category with 0% HCC probability.",
      "medicalReference": "LI-RADS v2018 - Definitely benign observations"
    },
    {
      "testName": "LR-2 - Probably Benign (Distinctive Nodule)",
      "category": "LR-2",
      "description": "Distinctive nodule <20mm without major HCC features - high probability benign",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "probably_benign"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-2 (Probably Benign)",
        "HCC Probability": "~14%",
        "Definition": "High probability benign; distinctive nodule <20mm without major HCC features",
        "Recommendation": "Return to routine surveillance; option for alternate imaging modality"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: Check benign_status = 'probably_benign'. Step 3: Return LR-2 category with ~14% HCC probability.",
      "medicalReference": "LI-RADS v2018 - Probably benign observations"
    },
    {
      "testName": "LR-M - Rim APHE (via Major Features)",
      "category": "LR-M",
      "description": "Rim arterial phase hyperenhancement suggests non-HCC malignancy (iCCA, metastases)",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": false,
        "observation_size": "25",
        "aphe": "rim"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-M (Probably/Definitely Malignant, Not HCC-Specific)",
        "Malignancy Probability": "93-100%",
        "HCC Probability": "29-44%",
        "Definition": "Rim arterial phase hyperenhancement suggests non-HCC malignancy",
        "Key Feature": "Rim APHE (peripheral > central enhancement)",
        "Differential Diagnosis": "Intrahepatic cholangiocarcinoma (iCCA), combined HCC-CCA, metastases",
        "Recommendation": "Biopsy recommended; multidisciplinary discussion"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: Check indeterminate status and no explicit LR-M features checked. Step 3: Detect aphe = 'rim'. Step 4: Return LR-M category due to rim APHE.",
      "medicalReference": "LI-RADS v2018 - LR-M targetoid features"
    },
    {
      "testName": "LR-M - Targetoid Features (Multiple)",
      "category": "LR-M",
      "description": "Multiple LR-M targetoid features present - peripheral washout and delayed central enhancement",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": true,
        "lrm_rim_aphe": true,
        "lrm_peripheral_washout": true,
        "lrm_delayed_central_enhancement": true,
        "lrm_targetoid_restriction": false,
        "lrm_targetoid_hbp": false,
        "lrm_infiltrative": false,
        "lrm_marked_restriction": false,
        "lrm_necrosis": false,
        "lrm_other": false
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-M (Probably/Definitely Malignant, Not HCC-Specific)",
        "Malignancy Probability": "93-100%",
        "HCC Probability": "29-44%",
        "Definition": "Malignant features present but not specific for HCC",
        "LR-M Features Identified": "Rim APHE; Peripheral washout; Delayed central enhancement",
        "Differential Diagnosis": "Atypical HCC, intrahepatic cholangiocarcinoma (iCCA), combined HCC-CCA, metastases",
        "Recommendation": "Biopsy recommended; multidisciplinary discussion"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: Check has_lrm_features = true. Step 3: Collect checked LR-M features: rim APHE, peripheral washout, delayed central enhancement. Step 4: Return LR-M category with feature list.",
      "medicalReference": "Cerny M, et al. RadioGraphics. 2018;38(7):1973-2001"
    },
    {
      "testName": "LR-M - Infiltrative Appearance (Non-targetoid)",
      "category": "LR-M",
      "description": "Infiltrative appearance - non-targetoid LR-M feature",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": true,
        "lrm_rim_aphe": false,
        "lrm_peripheral_washout": false,
        "lrm_delayed_central_enhancement": false,
        "lrm_targetoid_restriction": false,
        "lrm_targetoid_hbp": false,
        "lrm_infiltrative": true,
        "lrm_marked_restriction": false,
        "lrm_necrosis": false,
        "lrm_other": false
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-M (Probably/Definitely Malignant, Not HCC-Specific)",
        "Malignancy Probability": "93-100%",
        "HCC Probability": "29-44%",
        "Definition": "Malignant features present but not specific for HCC",
        "LR-M Features Identified": "Infiltrative appearance",
        "Differential Diagnosis": "Atypical HCC, intrahepatic cholangiocarcinoma (iCCA), combined HCC-CCA, metastases",
        "Recommendation": "Biopsy recommended; multidisciplinary discussion"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: Check has_lrm_features = true. Step 3: Only infiltrative appearance checked. Step 4: Return LR-M category with infiltrative feature.",
      "medicalReference": "LI-RADS v2018 - Non-targetoid LR-M features"
    },
    {
      "testName": "LR-3 - No APHE, <20mm, 0 Additional Features",
      "category": "LR-3",
      "description": "Observation without APHE, under 20mm, no additional major features",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": false,
        "observation_size": "15",
        "aphe": "none",
        "washout": "absent",
        "capsule": "absent",
        "threshold_growth": "absent",
        "ancillary_malignancy": "none",
        "ancillary_hcc": "none",
        "ancillary_benign": "none"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-3 (Intermediate Probability)",
        "HCC Probability": "38-40%",
        "Major Features": "Nonrim APHE: Absent | Size: 15 mm | Washout: Absent | Enhancing Capsule: Absent | Threshold Growth: Absent",
        "Additional Major Features Count": "0 of 3 (washout, capsule, threshold growth)",
        "Recommendation": "Repeat imaging in 3-6 months (same or alternate modality)"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass, indeterminate, no LR-M. Step 2: Size = 15mm (<20mm), no APHE. Step 3: Additional features = 0 (no washout, no capsule, no threshold growth). Step 4: No APHE + <20mm + 0 features = LR-3. Step 5: No ancillary adjustments.",
      "medicalReference": "LI-RADS v2018 Diagnostic Table - No APHE column"
    },
    {
      "testName": "LR-3 - No APHE, <20mm, 1 Additional Feature (Washout)",
      "category": "LR-3",
      "description": "No APHE, under 20mm, with washout only - still LR-3",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": false,
        "observation_size": "18",
        "aphe": "none",
        "washout": "present",
        "capsule": "absent",
        "threshold_growth": "absent",
        "ancillary_malignancy": "none",
        "ancillary_hcc": "none",
        "ancillary_benign": "none"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-3 (Intermediate Probability)",
        "HCC Probability": "38-40%",
        "Major Features": "Nonrim APHE: Absent | Size: 18 mm | Washout: Present | Enhancing Capsule: Absent | Threshold Growth: Absent",
        "Additional Major Features Count": "1 of 3 (washout, capsule, threshold growth)",
        "Recommendation": "Repeat imaging in 3-6 months (same or alternate modality)"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: Size = 18mm (<20mm), no APHE. Step 3: Additional features = 1 (washout present). Step 4: No APHE + <20mm + 1 feature = LR-3 (need 2 for LR-4). Step 5: No ancillary adjustments.",
      "medicalReference": "LI-RADS v2018 Diagnostic Table - No APHE, <20mm requires >=2 features for LR-4"
    },
    {
      "testName": "LR-4 - No APHE, <20mm, 2 Additional Features",
      "category": "LR-4",
      "description": "No APHE, under 20mm, with 2 additional major features - upgrades to LR-4",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": false,
        "observation_size": "15",
        "aphe": "none",
        "washout": "present",
        "capsule": "present",
        "threshold_growth": "absent",
        "ancillary_malignancy": "none",
        "ancillary_hcc": "none",
        "ancillary_benign": "none"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-4 (Probably HCC)",
        "HCC Probability": "67-74%",
        "Major Features": "Nonrim APHE: Absent | Size: 15 mm | Washout: Present | Enhancing Capsule: Present | Threshold Growth: Absent",
        "Additional Major Features Count": "2 of 3 (washout, capsule, threshold growth)",
        "Recommendation": "Multidisciplinary discussion; consider biopsy or short-term follow-up"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: Size = 15mm (<20mm), no APHE. Step 3: Additional features = 2 (washout + capsule). Step 4: No APHE + <20mm + 2 features = LR-4. Step 5: No ancillary adjustments.",
      "medicalReference": "LI-RADS v2018 Diagnostic Table - No APHE column"
    },
    {
      "testName": "LR-3 - No APHE, >=20mm, 0 Additional Features",
      "category": "LR-3",
      "description": "No APHE, 20mm or larger, no additional features - LR-3",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": false,
        "observation_size": "25",
        "aphe": "none",
        "washout": "absent",
        "capsule": "absent",
        "threshold_growth": "absent",
        "ancillary_malignancy": "none",
        "ancillary_hcc": "none",
        "ancillary_benign": "none"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-3 (Intermediate Probability)",
        "HCC Probability": "38-40%",
        "Major Features": "Nonrim APHE: Absent | Size: 25 mm | Washout: Absent | Enhancing Capsule: Absent | Threshold Growth: Absent",
        "Additional Major Features Count": "0 of 3 (washout, capsule, threshold growth)",
        "Recommendation": "Repeat imaging in 3-6 months (same or alternate modality)"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: Size = 25mm (>=20mm), no APHE. Step 3: Additional features = 0. Step 4: No APHE + >=20mm + 0 features = LR-3. Step 5: No ancillary adjustments.",
      "medicalReference": "LI-RADS v2018 Diagnostic Table - No APHE, >=20mm requires >=1 feature for LR-4"
    },
    {
      "testName": "LR-4 - No APHE, >=20mm, 1 Additional Feature",
      "category": "LR-4",
      "description": "No APHE, 20mm or larger, with 1 additional feature - LR-4",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": false,
        "observation_size": "20",
        "aphe": "none",
        "washout": "present",
        "capsule": "absent",
        "threshold_growth": "absent",
        "ancillary_malignancy": "none",
        "ancillary_hcc": "none",
        "ancillary_benign": "none"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-4 (Probably HCC)",
        "HCC Probability": "67-74%",
        "Major Features": "Nonrim APHE: Absent | Size: 20 mm | Washout: Present | Enhancing Capsule: Absent | Threshold Growth: Absent",
        "Additional Major Features Count": "1 of 3 (washout, capsule, threshold growth)",
        "Recommendation": "Multidisciplinary discussion; consider biopsy or short-term follow-up"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: Size = 20mm (>=20mm boundary), no APHE. Step 3: Additional features = 1 (washout). Step 4: No APHE + >=20mm + 1 feature = LR-4. Step 5: No ancillary adjustments.",
      "medicalReference": "LI-RADS v2018 Diagnostic Table - Size boundary at exactly 20mm"
    },
    {
      "testName": "LR-3 - With APHE, <10mm, 0 Additional Features",
      "category": "LR-3",
      "description": "Nonrim APHE present, under 10mm, no additional features - LR-3",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": false,
        "observation_size": "8",
        "aphe": "nonrim",
        "washout": "absent",
        "capsule": "absent",
        "threshold_growth": "absent",
        "ancillary_malignancy": "none",
        "ancillary_hcc": "none",
        "ancillary_benign": "none"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-3 (Intermediate Probability)",
        "HCC Probability": "38-40%",
        "Major Features": "Nonrim APHE: Present | Size: 8 mm | Washout: Absent | Enhancing Capsule: Absent | Threshold Growth: Absent",
        "Additional Major Features Count": "0 of 3 (washout, capsule, threshold growth)",
        "Recommendation": "Repeat imaging in 3-6 months (same or alternate modality)"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: Size = 8mm (<10mm), has nonrim APHE. Step 3: Additional features = 0. Step 4: APHE + <10mm + 0 features = LR-3. Step 5: No ancillary adjustments.",
      "medicalReference": "LI-RADS v2018 Diagnostic Table - <10mm cannot be LR-5"
    },
    {
      "testName": "LR-4 - With APHE, <10mm, 1 Additional Feature (Edge: 9mm)",
      "category": "LR-4",
      "description": "Boundary test: 9mm with APHE and 1 additional feature - LR-4 (cannot be LR-5)",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": false,
        "observation_size": "9",
        "aphe": "nonrim",
        "washout": "present",
        "capsule": "absent",
        "threshold_growth": "absent",
        "ancillary_malignancy": "none",
        "ancillary_hcc": "none",
        "ancillary_benign": "none"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-4 (Probably HCC)",
        "HCC Probability": "67-74%",
        "Major Features": "Nonrim APHE: Present | Size: 9 mm | Washout: Present | Enhancing Capsule: Absent | Threshold Growth: Absent",
        "Additional Major Features Count": "1 of 3 (washout, capsule, threshold growth)",
        "Recommendation": "Multidisciplinary discussion; consider biopsy or short-term follow-up",
        "Clinical Notes": "Observation <10mm cannot be categorized as LR-5 regardless of other features"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: Size = 9mm (<10mm boundary), has nonrim APHE. Step 3: Additional features = 1 (washout). Step 4: APHE + <10mm + 1 feature = LR-4 (max for <10mm). Step 5: Note added about <10mm LR-5 restriction.",
      "medicalReference": "LI-RADS v2018 - Observations <10mm cannot be LR-5"
    },
    {
      "testName": "LR-4 - With APHE, <10mm, 2+ Additional Features (Max LR-4)",
      "category": "LR-4",
      "description": "Under 10mm with APHE and multiple features - still capped at LR-4",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": false,
        "observation_size": "8",
        "aphe": "nonrim",
        "washout": "present",
        "capsule": "present",
        "threshold_growth": "present",
        "ancillary_malignancy": "none",
        "ancillary_hcc": "none",
        "ancillary_benign": "none"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-4 (Probably HCC)",
        "HCC Probability": "67-74%",
        "Major Features": "Nonrim APHE: Present | Size: 8 mm | Washout: Present | Enhancing Capsule: Present | Threshold Growth: Present",
        "Additional Major Features Count": "3 of 3 (washout, capsule, threshold growth)",
        "Recommendation": "Multidisciplinary discussion; consider biopsy or short-term follow-up",
        "Clinical Notes": "Observation <10mm cannot be categorized as LR-5 regardless of other features"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: Size = 8mm (<10mm), has nonrim APHE. Step 3: Additional features = 3 (all present). Step 4: APHE + <10mm + 3 features = LR-4 (cannot be LR-5). Step 5: Clinical note added.",
      "medicalReference": "LI-RADS v2018 - Size restriction for LR-5 diagnosis"
    },
    {
      "testName": "LR-3 - With APHE, 10-19mm, 0 Additional Features (Edge: 10mm)",
      "category": "LR-3",
      "description": "Boundary test: exactly 10mm with APHE but no additional features - LR-3",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": false,
        "observation_size": "10",
        "aphe": "nonrim",
        "washout": "absent",
        "capsule": "absent",
        "threshold_growth": "absent",
        "ancillary_malignancy": "none",
        "ancillary_hcc": "none",
        "ancillary_benign": "none"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-3 (Intermediate Probability)",
        "HCC Probability": "38-40%",
        "Major Features": "Nonrim APHE: Present | Size: 10 mm | Washout: Absent | Enhancing Capsule: Absent | Threshold Growth: Absent",
        "Additional Major Features Count": "0 of 3 (washout, capsule, threshold growth)",
        "Recommendation": "Repeat imaging in 3-6 months (same or alternate modality)"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: Size = 10mm (10-19mm range), has nonrim APHE. Step 3: Additional features = 0. Step 4: APHE + 10-19mm + 0 features = LR-3. Step 5: No ancillary adjustments.",
      "medicalReference": "LI-RADS v2018 - 10mm is lower boundary for potential LR-5"
    },
    {
      "testName": "LR-5 - With APHE, 10-19mm, Washout Present",
      "category": "LR-5",
      "description": "Classic LR-5: 10-19mm with APHE and washout - v2018 update allows LR-5",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": false,
        "observation_size": "15",
        "aphe": "nonrim",
        "washout": "present",
        "capsule": "absent",
        "threshold_growth": "absent",
        "ancillary_malignancy": "none",
        "ancillary_hcc": "none",
        "ancillary_benign": "none"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-5 (Definitely HCC)",
        "HCC Probability": "92-95%",
        "Major Features": "Nonrim APHE: Present | Size: 15 mm | Washout: Present | Enhancing Capsule: Absent | Threshold Growth: Absent",
        "Additional Major Features Count": "1 of 3 (washout, capsule, threshold growth)",
        "Recommendation": "Treat as HCC without biopsy; proceed to staging and treatment planning",
        "Clinical Notes": "LR-5 allows treatment without biopsy per AASLD guidelines; Verify OPTN criteria separately if patient is a transplant candidate"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: Size = 15mm (10-19mm range), has nonrim APHE. Step 3: Additional features = 1 (washout). Step 4: APHE + 10-19mm + washout = LR-5 (key v2018 update). Step 5: Clinical notes added.",
      "medicalReference": "Chernyak V, et al. Radiology 2018 - v2018 removed US visibility requirement for 10-19mm + APHE + washout"
    },
    {
      "testName": "LR-5 - With APHE, 10-19mm, Threshold Growth Present",
      "category": "LR-5",
      "description": "10-19mm with APHE and threshold growth - LR-5",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": false,
        "observation_size": "12",
        "aphe": "nonrim",
        "washout": "absent",
        "capsule": "absent",
        "threshold_growth": "present",
        "ancillary_malignancy": "none",
        "ancillary_hcc": "none",
        "ancillary_benign": "none"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-5 (Definitely HCC)",
        "HCC Probability": "92-95%",
        "Major Features": "Nonrim APHE: Present | Size: 12 mm | Washout: Absent | Enhancing Capsule: Absent | Threshold Growth: Present",
        "Additional Major Features Count": "1 of 3 (washout, capsule, threshold growth)",
        "Recommendation": "Treat as HCC without biopsy; proceed to staging and treatment planning",
        "Clinical Notes": "Threshold growth defined as >=50% size increase in <=6 months or new observation >=10mm; LR-5 allows treatment without biopsy per AASLD guidelines; Verify OPTN criteria separately if patient is a transplant candidate"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: Size = 12mm (10-19mm range), has nonrim APHE. Step 3: Additional features = 1 (threshold growth). Step 4: APHE + 10-19mm + threshold growth = LR-5. Step 5: Clinical notes added about threshold growth definition.",
      "medicalReference": "LI-RADS v2018 - Threshold growth >= 50% in <= 6 months or new >= 10mm"
    },
    {
      "testName": "LR-4 - With APHE, 10-19mm, Capsule Only (Edge: 19mm)",
      "category": "LR-4",
      "description": "Boundary test: 19mm with APHE and capsule only (no washout/growth) - LR-4",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": false,
        "observation_size": "19",
        "aphe": "nonrim",
        "washout": "absent",
        "capsule": "present",
        "threshold_growth": "absent",
        "ancillary_malignancy": "none",
        "ancillary_hcc": "none",
        "ancillary_benign": "none"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-4 (Probably HCC)",
        "HCC Probability": "67-74%",
        "Major Features": "Nonrim APHE: Present | Size: 19 mm | Washout: Absent | Enhancing Capsule: Present | Threshold Growth: Absent",
        "Additional Major Features Count": "1 of 3 (washout, capsule, threshold growth)",
        "Recommendation": "Multidisciplinary discussion; consider biopsy or short-term follow-up",
        "Clinical Notes": "At 10-19mm with APHE, capsule alone (without washout or threshold growth) yields LR-4, not LR-5"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: Size = 19mm (10-19mm range), has nonrim APHE. Step 3: Additional features = 1 (capsule only). Step 4: APHE + 10-19mm + capsule alone = LR-4 (capsule alone doesn't qualify for LR-5). Step 5: Clinical note added.",
      "medicalReference": "LI-RADS v2018 - Capsule alone at 10-19mm = LR-4"
    },
    {
      "testName": "LR-5 - With APHE, 10-19mm, 2 Additional Features",
      "category": "LR-5",
      "description": "10-19mm with APHE and 2 additional features (washout + capsule) - LR-5",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": false,
        "observation_size": "14",
        "aphe": "nonrim",
        "washout": "present",
        "capsule": "present",
        "threshold_growth": "absent",
        "ancillary_malignancy": "none",
        "ancillary_hcc": "none",
        "ancillary_benign": "none"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-5 (Definitely HCC)",
        "HCC Probability": "92-95%",
        "Major Features": "Nonrim APHE: Present | Size: 14 mm | Washout: Present | Enhancing Capsule: Present | Threshold Growth: Absent",
        "Additional Major Features Count": "2 of 3 (washout, capsule, threshold growth)",
        "Recommendation": "Treat as HCC without biopsy; proceed to staging and treatment planning",
        "Clinical Notes": "LR-5 allows treatment without biopsy per AASLD guidelines; Verify OPTN criteria separately if patient is a transplant candidate"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: Size = 14mm (10-19mm range), has nonrim APHE. Step 3: Additional features = 2 (washout + capsule). Step 4: APHE + 10-19mm + 2 features = LR-5. Step 5: Clinical notes added.",
      "medicalReference": "LI-RADS v2018 Diagnostic Table"
    },
    {
      "testName": "LR-4 - With APHE, >=20mm, 0 Additional Features (Edge: 20mm)",
      "category": "LR-4",
      "description": "Boundary test: exactly 20mm with APHE but no additional features - LR-4",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": false,
        "observation_size": "20",
        "aphe": "nonrim",
        "washout": "absent",
        "capsule": "absent",
        "threshold_growth": "absent",
        "ancillary_malignancy": "none",
        "ancillary_hcc": "none",
        "ancillary_benign": "none"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-4 (Probably HCC)",
        "HCC Probability": "67-74%",
        "Major Features": "Nonrim APHE: Present | Size: 20 mm | Washout: Absent | Enhancing Capsule: Absent | Threshold Growth: Absent",
        "Additional Major Features Count": "0 of 3 (washout, capsule, threshold growth)",
        "Recommendation": "Multidisciplinary discussion; consider biopsy or short-term follow-up"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: Size = 20mm (>=20mm range), has nonrim APHE. Step 3: Additional features = 0. Step 4: APHE + >=20mm + 0 features = LR-4. Step 5: No ancillary adjustments.",
      "medicalReference": "LI-RADS v2018 - 20mm threshold for simplified criteria"
    },
    {
      "testName": "LR-5 - With APHE, >=20mm, 1 Additional Feature",
      "category": "LR-5",
      "description": "Large lesion (>=20mm) with APHE and any 1 additional feature - LR-5",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": false,
        "observation_size": "35",
        "aphe": "nonrim",
        "washout": "absent",
        "capsule": "present",
        "threshold_growth": "absent",
        "ancillary_malignancy": "none",
        "ancillary_hcc": "none",
        "ancillary_benign": "none"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-5 (Definitely HCC)",
        "HCC Probability": "92-95%",
        "Major Features": "Nonrim APHE: Present | Size: 35 mm | Washout: Absent | Enhancing Capsule: Present | Threshold Growth: Absent",
        "Additional Major Features Count": "1 of 3 (washout, capsule, threshold growth)",
        "Recommendation": "Treat as HCC without biopsy; proceed to staging and treatment planning",
        "Clinical Notes": "LR-5 allows treatment without biopsy per AASLD guidelines; Verify OPTN criteria separately if patient is a transplant candidate"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: Size = 35mm (>=20mm), has nonrim APHE. Step 3: Additional features = 1 (capsule). Step 4: APHE + >=20mm + 1 feature = LR-5. Step 5: Clinical notes added.",
      "medicalReference": "LI-RADS v2018 - Large lesions (>=20mm) with APHE need only 1 additional feature for LR-5"
    },
    {
      "testName": "Ancillary Upgrade - LR-3 to LR-4 (Malignancy Features)",
      "category": "Ancillary Features",
      "description": "LR-3 upgraded to LR-4 by ancillary features favoring malignancy",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": false,
        "observation_size": "15",
        "aphe": "none",
        "washout": "absent",
        "capsule": "absent",
        "threshold_growth": "absent",
        "ancillary_malignancy": "restricted_diffusion",
        "ancillary_hcc": "none",
        "ancillary_benign": "none"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-4 (Probably HCC)",
        "HCC Probability": "67-74%",
        "Major Features": "Nonrim APHE: Absent | Size: 15 mm | Washout: Absent | Enhancing Capsule: Absent | Threshold Growth: Absent",
        "Additional Major Features Count": "0 of 3 (washout, capsule, threshold growth)",
        "Recommendation": "Multidisciplinary discussion; consider biopsy or short-term follow-up",
        "Base Category (before ancillary)": "LR-3",
        "Ancillary Adjustment": "Upgraded from LR-3 to LR-4 based on ancillary features favoring malignancy"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: Size = 15mm, no APHE, 0 additional features = base LR-3. Step 3: Ancillary malignancy feature present (restricted diffusion). Step 4: No benign features - can upgrade. Step 5: Upgrade LR-3 -> LR-4.",
      "medicalReference": "Cerny M, et al. RadioGraphics 2018 - Ancillary features can upgrade by 1, max LR-4"
    },
    {
      "testName": "Ancillary Upgrade - LR-3 to LR-4 (HCC-Specific Features)",
      "category": "Ancillary Features",
      "description": "LR-3 upgraded to LR-4 by ancillary features favoring HCC in particular",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": false,
        "observation_size": "18",
        "aphe": "nonrim",
        "washout": "absent",
        "capsule": "absent",
        "threshold_growth": "absent",
        "ancillary_malignancy": "none",
        "ancillary_hcc": "mosaic",
        "ancillary_benign": "none"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-4 (Probably HCC)",
        "HCC Probability": "67-74%",
        "Major Features": "Nonrim APHE: Present | Size: 18 mm | Washout: Absent | Enhancing Capsule: Absent | Threshold Growth: Absent",
        "Additional Major Features Count": "0 of 3 (washout, capsule, threshold growth)",
        "Recommendation": "Multidisciplinary discussion; consider biopsy or short-term follow-up",
        "Base Category (before ancillary)": "LR-3",
        "Ancillary Adjustment": "Upgraded from LR-3 to LR-4 based on ancillary features favoring malignancy"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: Size = 18mm (10-19mm), APHE present, 0 additional features = base LR-3. Step 3: Ancillary HCC feature present (mosaic architecture). Step 4: No benign features - can upgrade. Step 5: Upgrade LR-3 -> LR-4.",
      "medicalReference": "LI-RADS v2018 - HCC-specific ancillary features"
    },
    {
      "testName": "Ancillary No Upgrade - Already LR-4 (Cannot Exceed LR-4)",
      "category": "Ancillary Features",
      "description": "LR-4 cannot be upgraded to LR-5 by ancillary features",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": false,
        "observation_size": "9",
        "aphe": "nonrim",
        "washout": "present",
        "capsule": "absent",
        "threshold_growth": "absent",
        "ancillary_malignancy": "restricted_diffusion",
        "ancillary_hcc": "fat_in_mass",
        "ancillary_benign": "none"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-4 (Probably HCC)",
        "HCC Probability": "67-74%",
        "Major Features": "Nonrim APHE: Present | Size: 9 mm | Washout: Present | Enhancing Capsule: Absent | Threshold Growth: Absent",
        "Additional Major Features Count": "1 of 3 (washout, capsule, threshold growth)",
        "Recommendation": "Multidisciplinary discussion; consider biopsy or short-term follow-up",
        "Clinical Notes": "Observation <10mm cannot be categorized as LR-5 regardless of other features"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: Size = 9mm (<10mm), APHE + washout = base LR-4. Step 3: Multiple ancillary malignancy/HCC features present. Step 4: Cannot upgrade beyond LR-4 (ancillary rule). Step 5: Category remains LR-4.",
      "medicalReference": "LI-RADS v2018 - Ancillary features cannot upgrade to LR-5"
    },
    {
      "testName": "Ancillary Downgrade - LR-5 to LR-4 (Benign Features)",
      "category": "Ancillary Features",
      "description": "LR-5 downgraded to LR-4 by ancillary features favoring benignity",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": false,
        "observation_size": "25",
        "aphe": "nonrim",
        "washout": "present",
        "capsule": "absent",
        "threshold_growth": "absent",
        "ancillary_malignancy": "none",
        "ancillary_hcc": "none",
        "ancillary_benign": "size_stability"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-4 (Probably HCC)",
        "HCC Probability": "67-74%",
        "Major Features": "Nonrim APHE: Present | Size: 25 mm | Washout: Present | Enhancing Capsule: Absent | Threshold Growth: Absent",
        "Additional Major Features Count": "1 of 3 (washout, capsule, threshold growth)",
        "Recommendation": "Multidisciplinary discussion; consider biopsy or short-term follow-up",
        "Base Category (before ancillary)": "LR-5",
        "Ancillary Adjustment": "Downgraded from LR-5 to LR-4 based on ancillary features favoring benignity"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: Size = 25mm (>=20mm), APHE + washout = base LR-5. Step 3: Ancillary benign feature present (size stability >=2 years). Step 4: No malignancy features - can downgrade. Step 5: Downgrade LR-5 -> LR-4.",
      "medicalReference": "LI-RADS v2018 - Ancillary features favoring benignity"
    },
    {
      "testName": "Ancillary Downgrade - LR-4 to LR-3 (Benign Features)",
      "category": "Ancillary Features",
      "description": "LR-4 downgraded to LR-3 by ancillary features favoring benignity",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": false,
        "observation_size": "15",
        "aphe": "none",
        "washout": "present",
        "capsule": "present",
        "threshold_growth": "absent",
        "ancillary_malignancy": "none",
        "ancillary_hcc": "none",
        "ancillary_benign": "marked_t2"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-3 (Intermediate Probability)",
        "HCC Probability": "38-40%",
        "Major Features": "Nonrim APHE: Absent | Size: 15 mm | Washout: Present | Enhancing Capsule: Present | Threshold Growth: Absent",
        "Additional Major Features Count": "2 of 3 (washout, capsule, threshold growth)",
        "Recommendation": "Repeat imaging in 3-6 months (same or alternate modality)",
        "Base Category (before ancillary)": "LR-4",
        "Ancillary Adjustment": "Downgraded from LR-4 to LR-3 based on ancillary features favoring benignity"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: Size = 15mm (<20mm), no APHE, 2 additional features = base LR-4. Step 3: Ancillary benign feature present (marked T2 hyperintensity). Step 4: No malignancy features - can downgrade. Step 5: Downgrade LR-4 -> LR-3.",
      "medicalReference": "LI-RADS v2018 - Marked T2 hyperintensity favors benignity"
    },
    {
      "testName": "Ancillary Conflict - No Adjustment Applied",
      "category": "Ancillary Features",
      "description": "Conflicting ancillary features (both malignancy and benignity) - no adjustment",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": false,
        "observation_size": "16",
        "aphe": "nonrim",
        "washout": "absent",
        "capsule": "absent",
        "threshold_growth": "absent",
        "ancillary_malignancy": "hbp_hypo",
        "ancillary_hcc": "none",
        "ancillary_benign": "size_reduction"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-3 (Intermediate Probability)",
        "HCC Probability": "38-40%",
        "Major Features": "Nonrim APHE: Present | Size: 16 mm | Washout: Absent | Enhancing Capsule: Absent | Threshold Growth: Absent",
        "Additional Major Features Count": "0 of 3 (washout, capsule, threshold growth)",
        "Recommendation": "Repeat imaging in 3-6 months (same or alternate modality)"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: Size = 16mm (10-19mm), APHE present, 0 additional features = base LR-3. Step 3: Both malignancy feature (HBP hypointensity) AND benign feature (size reduction) present. Step 4: Conflicting features - no adjustment applied. Step 5: Category remains LR-3.",
      "medicalReference": "LI-RADS v2018 - Conflicting ancillary features cancel out"
    },
    {
      "testName": "Ancillary No Downgrade Below LR-3",
      "category": "Ancillary Features",
      "description": "LR-3 cannot be downgraded further by benign features",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": false,
        "observation_size": "12",
        "aphe": "nonrim",
        "washout": "absent",
        "capsule": "absent",
        "threshold_growth": "absent",
        "ancillary_malignancy": "none",
        "ancillary_hcc": "none",
        "ancillary_benign": "hbp_iso"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-3 (Intermediate Probability)",
        "HCC Probability": "38-40%",
        "Major Features": "Nonrim APHE: Present | Size: 12 mm | Washout: Absent | Enhancing Capsule: Absent | Threshold Growth: Absent",
        "Additional Major Features Count": "0 of 3 (washout, capsule, threshold growth)",
        "Recommendation": "Repeat imaging in 3-6 months (same or alternate modality)"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: Size = 12mm (10-19mm), APHE present, 0 features = base LR-3. Step 3: Benign feature present (HBP isointensity). Step 4: Already LR-3 - cannot downgrade further. Step 5: Category remains LR-3.",
      "medicalReference": "LI-RADS v2018 - LR-3 is minimum category from diagnostic table"
    },
    {
      "testName": "Complete Case - All Major Features Present, Large Lesion",
      "category": "Complete Scenarios",
      "description": "Large lesion with APHE and all 3 additional major features - definite HCC",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": false,
        "observation_size": "45",
        "aphe": "nonrim",
        "washout": "present",
        "capsule": "present",
        "threshold_growth": "present",
        "ancillary_malignancy": "none",
        "ancillary_hcc": "none",
        "ancillary_benign": "none"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-5 (Definitely HCC)",
        "HCC Probability": "92-95%",
        "Major Features": "Nonrim APHE: Present | Size: 45 mm | Washout: Present | Enhancing Capsule: Present | Threshold Growth: Present",
        "Additional Major Features Count": "3 of 3 (washout, capsule, threshold growth)",
        "Recommendation": "Treat as HCC without biopsy; proceed to staging and treatment planning",
        "Clinical Notes": "Threshold growth defined as >=50% size increase in <=6 months or new observation >=10mm; LR-5 allows treatment without biopsy per AASLD guidelines; Verify OPTN criteria separately if patient is a transplant candidate"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: Size = 45mm (>=20mm), APHE present, 3 additional features. Step 3: APHE + >=20mm + 1+ features = LR-5. Step 4: No ancillary adjustments needed. Step 5: All clinical notes added.",
      "medicalReference": "LI-RADS v2018 Diagnostic Table"
    },
    {
      "testName": "Input Validation - Missing Size and APHE",
      "category": "Error Handling",
      "description": "Error returned when required fields (size and APHE) are not completed",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": false,
        "observation_size": "",
        "aphe": ""
      },
      "expectedOutputs": {
        "Error": "Please complete observation size and APHE assessment to determine LI-RADS category."
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass, indeterminate, no LR-M. Step 2: Check observation_size is empty. Step 3: Return error requesting completion of required fields.",
      "medicalReference": "N/A - Input validation"
    },
    {
      "testName": "LR-M - No Features Selected (Checkbox Only)",
      "category": "LR-M Edge Case",
      "description": "LR-M features checkbox enabled but no specific features selected - continues to diagnostic table",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": true,
        "lrm_rim_aphe": false,
        "lrm_peripheral_washout": false,
        "lrm_delayed_central_enhancement": false,
        "lrm_targetoid_restriction": false,
        "lrm_targetoid_hbp": false,
        "lrm_infiltrative": false,
        "lrm_marked_restriction": false,
        "lrm_necrosis": false,
        "lrm_other": false,
        "observation_size": "20",
        "aphe": "nonrim",
        "washout": "present",
        "capsule": "absent",
        "threshold_growth": "absent",
        "ancillary_malignancy": "none",
        "ancillary_hcc": "none",
        "ancillary_benign": "none"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-5 (Definitely HCC)",
        "HCC Probability": "92-95%",
        "Major Features": "Nonrim APHE: Present | Size: 20 mm | Washout: Present | Enhancing Capsule: Absent | Threshold Growth: Absent",
        "Additional Major Features Count": "1 of 3 (washout, capsule, threshold growth)",
        "Recommendation": "Treat as HCC without biopsy; proceed to staging and treatment planning",
        "Clinical Notes": "LR-5 allows treatment without biopsy per AASLD guidelines; Verify OPTN criteria separately if patient is a transplant candidate"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: has_lrm_features = true but no individual features checked = 0 LR-M features. Step 3: Falls through to diagnostic table. Step 4: Size = 20mm (>=20mm), APHE + washout = LR-5. Step 5: Clinical notes added.",
      "medicalReference": "LI-RADS v2018 - LR-M requires at least one targetoid or non-targetoid feature"
    },
    {
      "testName": "LR-M - All Non-Targetoid Features",
      "category": "LR-M",
      "description": "Multiple non-targetoid LR-M features present",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": true,
        "lrm_rim_aphe": false,
        "lrm_peripheral_washout": false,
        "lrm_delayed_central_enhancement": false,
        "lrm_targetoid_restriction": false,
        "lrm_targetoid_hbp": false,
        "lrm_infiltrative": true,
        "lrm_marked_restriction": true,
        "lrm_necrosis": true,
        "lrm_other": true
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-M (Probably/Definitely Malignant, Not HCC-Specific)",
        "Malignancy Probability": "93-100%",
        "HCC Probability": "29-44%",
        "Definition": "Malignant features present but not specific for HCC",
        "LR-M Features Identified": "Infiltrative appearance; Marked diffusion restriction; Necrosis/severe ischemia; Other non-HCC malignancy features",
        "Differential Diagnosis": "Atypical HCC, intrahepatic cholangiocarcinoma (iCCA), combined HCC-CCA, metastases",
        "Recommendation": "Biopsy recommended; multidisciplinary discussion"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: has_lrm_features = true. Step 3: Collect non-targetoid features: infiltrative, marked restriction, necrosis, other. Step 4: Return LR-M with all 4 features listed.",
      "medicalReference": "LI-RADS v2018 - Non-targetoid LR-M features"
    },
    {
      "testName": "Decimal Size - 9.9mm (Just Under 10mm Threshold)",
      "category": "Edge Cases",
      "description": "Decimal precision test: 9.9mm should be treated as <10mm",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": false,
        "observation_size": "9.9",
        "aphe": "nonrim",
        "washout": "present",
        "capsule": "present",
        "threshold_growth": "present",
        "ancillary_malignancy": "none",
        "ancillary_hcc": "none",
        "ancillary_benign": "none"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-4 (Probably HCC)",
        "HCC Probability": "67-74%",
        "Major Features": "Nonrim APHE: Present | Size: 9.9 mm | Washout: Present | Enhancing Capsule: Present | Threshold Growth: Present",
        "Additional Major Features Count": "3 of 3 (washout, capsule, threshold growth)",
        "Recommendation": "Multidisciplinary discussion; consider biopsy or short-term follow-up",
        "Clinical Notes": "Observation <10mm cannot be categorized as LR-5 regardless of other features"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: Size = 9.9mm (< 10mm), APHE present. Step 3: All 3 additional features present. Step 4: <10mm cap at LR-4 regardless of features. Step 5: Clinical note added.",
      "medicalReference": "LI-RADS v2018 - Size precision handling"
    },
    {
      "testName": "Decimal Size - 19.9mm (Just Under 20mm Threshold)",
      "category": "Edge Cases",
      "description": "Decimal precision test: 19.9mm should use 10-19mm criteria",
      "inputs": {
        "high_risk_population": true,
        "study_adequate": true,
        "tumor_in_vein": false,
        "benign_status": "indeterminate",
        "has_lrm_features": false,
        "observation_size": "19.9",
        "aphe": "nonrim",
        "washout": "absent",
        "capsule": "present",
        "threshold_growth": "absent",
        "ancillary_malignancy": "none",
        "ancillary_hcc": "none",
        "ancillary_benign": "none"
      },
      "expectedOutputs": {
        "LI-RADS Category": "LR-4 (Probably HCC)",
        "HCC Probability": "67-74%",
        "Major Features": "Nonrim APHE: Present | Size: 19.9 mm | Washout: Absent | Enhancing Capsule: Present | Threshold Growth: Absent",
        "Additional Major Features Count": "1 of 3 (washout, capsule, threshold growth)",
        "Recommendation": "Multidisciplinary discussion; consider biopsy or short-term follow-up",
        "Clinical Notes": "At 10-19mm with APHE, capsule alone (without washout or threshold growth) yields LR-4, not LR-5"
      },
      "calculationSteps": "Step 1: Check prerequisites - all pass. Step 2: Size = 19.9mm (10-19mm range), APHE present. Step 3: Only capsule present (no washout/growth). Step 4: 10-19mm + APHE + capsule alone = LR-4. Step 5: Clinical note about capsule-only rule.",
      "medicalReference": "LI-RADS v2018 - Capsule alone at 10-19mm = LR-4"
    }
  ],
  "algorithmNotes": [
    "LI-RADS v2018 applies only to patients at risk for HCC: cirrhosis (non-vascular/congenital), chronic hepatitis B, or prior HCC",
    "The diagnostic algorithm is hierarchical: prerequisites -> LR-NC -> LR-TIV -> LR-1/LR-2 -> LR-M -> diagnostic table",
    "Size thresholds: <10mm (cannot be LR-5), 10-19mm (intermediate criteria), >=20mm (simplified criteria)",
    "Major features: nonrim APHE, observation size, nonperipheral washout, enhancing capsule, threshold growth",
    "v2018 key change: 10-19mm observations with APHE + washout now categorized as LR-5 (removed US visibility requirement)",
    "Threshold growth defined as >=50% size increase in <=6 months OR new observation >=10mm (matches OPTN)",
    "At 10-19mm with APHE: washout OR threshold growth = LR-5; capsule alone = LR-4; >=2 features = LR-5",
    "At >=20mm with APHE: 0 features = LR-4; >=1 feature = LR-5",
    "Without APHE at <20mm: >=2 features = LR-4; <2 features = LR-3",
    "Without APHE at >=20mm: >=1 feature = LR-4; 0 features = LR-3",
    "Ancillary features can upgrade by 1 (max LR-4, never to LR-5) or downgrade by 1",
    "Conflicting ancillary features (both malignancy AND benignity) result in no adjustment",
    "LR-M features take precedence over diagnostic table - any targetoid or qualifying non-targetoid feature = LR-M",
    "Rim APHE alone (in major features section) also triggers LR-M classification"
  ],
  "hccProbabilities": {
    "LR-1": "0%",
    "LR-2": "~14%",
    "LR-3": "38-40%",
    "LR-4": "67-74%",
    "LR-5": "92-95%",
    "LR-M": "29-44% (malignancy 93-100%)"
  }
}
